• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压降低、体重减轻与参与基于数字应用程序的高血压护理项目之间的关系:观察性研究。

Relationships Between Blood Pressure Reduction, Weight Loss, and Engagement in a Digital App-Based Hypertension Care Program: Observational Study.

作者信息

Branch OraLee H, Rikhy Mohit, Auster-Gussman Lisa A, Lockwood Kimberly G, Graham Sarah A

机构信息

Lark Technologies, Inc, Mountain View, CA, United States.

出版信息

JMIR Form Res. 2022 Oct 27;6(10):e38215. doi: 10.2196/38215.

DOI:10.2196/38215
PMID:36301618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9650575/
Abstract

BACKGROUND

Home blood pressure (BP) monitoring is recommended for people with hypertension; however, meta-analyses have demonstrated that BP improvements are related to additional coaching support in combination with self-monitoring, with little or no effect of self-monitoring alone. High-contact coaching requires substantial resources and may be difficult to deliver via human coaching models.

OBJECTIVE

This observational study assessed changes in BP and body weight following participation in a fully digital program called Lark Hypertension Care with coaching powered by artificial intelligence (AI).

METHODS

Participants (N=864) had a baseline systolic BP (SBP) ≥120 mm Hg, provided their baseline body weight, and had reached at least their third month in the program. The primary outcome was the change in SBP at 3 and 6 months, with secondary outcomes of change in body weight and associations of changes in SBP and body weight with participant demographics, characteristics, and program engagement.

RESULTS

By month 3, there was a significant drop of -5.4 mm Hg (95% CI -6.5 to -4.3; P<.001) in mean SBP from baseline. BP did not change significantly (ie, the SBP drop maintained) from 3 to 6 months for participants who provided readings at both time points (P=.49). Half of the participants achieved a clinically meaningful drop of ≥5 mm Hg by month 3 (178/349, 51.0%) and month 6 (98/199, 49.2%). The magnitude of the drop depended on starting SBP. Participants classified as hypertension stage 2 had the largest mean drop in SBP of -12.4 mm Hg (SE 1.2 mm Hg) by month 3 and -13.0 mm Hg (SE 1.6 mm Hg) by month 6; participants classified as hypertension stage 1 lowered by -5.2 mm Hg (SE 0.8) mm Hg by month 3 and -7.3 mm Hg (SE 1.3 mm Hg) by month 6; participants classified as elevated lowered by -1.1 mm Hg (SE 0.7 mm Hg) by month 3 but did not drop by month 6. Starting SBP (β=.11; P<.001), percent weight change (β=-.36; P=.02), and initial BMI (β=-.56; P<.001) were significantly associated with the likelihood of lowering SBP ≥5 mm Hg by month 3. Percent weight change acted as a mediator of the relationship between program engagement and drop in SBP. The bootstrapped unstandardized indirect effect was -0.0024 (95% CI -0.0052 to 0; P=.002).

CONCLUSIONS

A hypertension care program with coaching powered by AI was associated with a clinically meaningful reduction in SBP following 3 and 6 months of program participation. Percent weight change was significantly associated with the likelihood of achieving a ≥5 mm Hg drop in SBP. An AI-powered solution may offer a scalable approach to helping individuals with hypertension achieve clinically meaningful reductions in their BP and associated risk of cardiovascular disease and other serious adverse outcomes via healthy lifestyle changes such as weight loss.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/c1aa90a4d4c9/formative_v6i10e38215_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/aeda09d301b0/formative_v6i10e38215_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/a6a1bc02c54b/formative_v6i10e38215_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/c1aa90a4d4c9/formative_v6i10e38215_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/aeda09d301b0/formative_v6i10e38215_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/a6a1bc02c54b/formative_v6i10e38215_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5231/9650575/c1aa90a4d4c9/formative_v6i10e38215_fig3.jpg
摘要

背景

对于高血压患者,建议进行家庭血压监测;然而,荟萃分析表明,血压改善与自我监测相结合的额外指导支持有关,单独的自我监测几乎没有效果或没有效果。高接触式指导需要大量资源,并且通过人工指导模式可能难以提供。

目的

这项观察性研究评估了参与名为Lark高血压护理的全数字项目(由人工智能提供指导)后血压和体重的变化。

方法

参与者(N = 864)的基线收缩压(SBP)≥120 mmHg,提供了他们的基线体重,并且在该项目中至少达到了第三个月。主要结局是3个月和6个月时SBP的变化,次要结局是体重变化以及SBP和体重变化与参与者人口统计学、特征和项目参与度的关联。

结果

到第3个月时,平均SBP较基线显著下降了-5.4 mmHg(95% CI -6.5至-4.3;P <.001)。对于在两个时间点都提供读数的参与者,血压从3个月到6个月没有显著变化(即SBP下降保持)(P =.49)。一半的参与者在第3个月(178/349,51.0%)和第6个月(98/199,49.2%)实现了临床上有意义的下降≥5 mmHg。下降幅度取决于起始SBP。被分类为高血压2期的参与者在第3个月时SBP平均下降幅度最大,为-12.4 mmHg(标准误1.2 mmHg),在第6个月时为-13.0 mmHg(标准误1.6 mmHg);被分类为高血压1期的参与者在第3个月时下降了-5.2 mmHg(标准误0.8 mmHg),在第6个月时下降了-7.3 mmHg(标准误1.3 mmHg);被分类为血压升高的参与者在第3个月时下降了-1.1 mmHg(标准误0.7 mmHg),但在第6个月时没有下降。起始SBP(β =.11;P <.001)、体重变化百分比(β = -.36;P =.02)和初始BMI(β = -.56;P <.001)与到第3个月时SBP降低≥5 mmHg的可能性显著相关。体重变化百分比是项目参与度与SBP下降之间关系的中介变量。自抽样的非标准化间接效应为-0.0024(95% CI -0.0052至0;P =.002)。

结论

一个由人工智能提供指导的高血压护理项目与项目参与3个月和6个月后临床上有意义的SBP降低相关。体重变化百分比与SBP下降≥5 mmHg的可能性显著相关。一个由人工智能驱动的解决方案可能提供一种可扩展的方法,通过体重减轻等健康生活方式改变,帮助高血压患者实现临床上有意义的血压降低以及降低心血管疾病和其他严重不良结局的相关风险。

相似文献

1
Relationships Between Blood Pressure Reduction, Weight Loss, and Engagement in a Digital App-Based Hypertension Care Program: Observational Study.血压降低、体重减轻与参与基于数字应用程序的高血压护理项目之间的关系:观察性研究。
JMIR Form Res. 2022 Oct 27;6(10):e38215. doi: 10.2196/38215.
2
The Effect of an AI-Based, Autonomous, Digital Health Intervention Using Precise Lifestyle Guidance on Blood Pressure in Adults With Hypertension: Single-Arm Nonrandomized Trial.基于人工智能的自主数字健康干预结合精准生活方式指导对成人高血压患者血压的影响:单臂非随机试验
JMIR Cardio. 2024 May 28;8:e51916. doi: 10.2196/51916.
3
Long-Term Results of a Digital Hypertension Self-Management Program: Retrospective Cohort Study.数字高血压自我管理项目的长期结果:回顾性队列研究
JMIR Cardio. 2023 Aug 24;7:e43489. doi: 10.2196/43489.
4
Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program.评估参与移动技术血压自我管理项目的成年人的高血压控制情况。
JAMA Netw Open. 2021 Oct 1;4(10):e2127008. doi: 10.1001/jamanetworkopen.2021.27008.
5
Evaluating a New Digital App-Based Program for Heart Health: Feasibility and Acceptability Pilot Study.评估一项基于数字应用程序的心脏健康新计划:可行性和可接受性试点研究。
JMIR Form Res. 2024 May 24;8:e50446. doi: 10.2196/50446.
6
Weight loss in a digital app-based diabetes prevention program powered by artificial intelligence.基于人工智能的数字应用程序糖尿病预防计划中的体重减轻
Digit Health. 2022 Oct 9;8:20552076221130619. doi: 10.1177/20552076221130619. eCollection 2022 Jan-Dec.
7
Personalized Hypertension Management Using Patient-Generated Health Data Integrated With Electronic Health Records (EMPOWER-H): Six-Month Pre-Post Study.使用整合电子健康记录的患者生成健康数据进行个性化高血压管理(EMPOWER-H):六个月前后研究。
J Med Internet Res. 2017 Sep 19;19(9):e311. doi: 10.2196/jmir.7831.
8
Empowerment-based nutrition interventions on blood pressure: a randomized comparative effectiveness trial.基于赋权的营养干预对血压的影响:一项随机对照效果试验。
Front Public Health. 2023 Nov 13;11:1277355. doi: 10.3389/fpubh.2023.1277355. eCollection 2023.
9
Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.数字药物改善血压控制不佳的高血压患者和2型糖尿病患者临床结局的有效性:前瞻性、开放标签、整群随机试验性临床试验
J Med Internet Res. 2017 Jul 11;19(7):e246. doi: 10.2196/jmir.7833.
10
Effect of Home Blood Pressure Monitoring via a Smartphone Hypertension Coaching Application or Tracking Application on Adults With Uncontrolled Hypertension: A Randomized Clinical Trial.智能手机高血压管理应用程序中的家庭血压监测或跟踪应用程序对血压控制不佳的成年人的影响:一项随机临床试验。
JAMA Netw Open. 2020 Mar 2;3(3):e200255. doi: 10.1001/jamanetworkopen.2020.0255.

引用本文的文献

1
Smartphone application-based interventions for cardiometabolic risk factor management: A systematic review and meta-analysis.基于智能手机应用程序的心血管代谢危险因素管理干预措施:一项系统评价和荟萃分析。
Hypertens Res. 2025 Sep 3. doi: 10.1038/s41440-025-02365-y.
2
Artificial Intelligence in Health Promotion and Disease Reduction: Rapid Review.健康促进与疾病预防中的人工智能:快速综述
J Med Internet Res. 2025 Aug 1;27:e70381. doi: 10.2196/70381.
3
Cardiac Self-Efficacy Improvement in a Digital Heart Health Program: Secondary Analysis From a Feasibility and Acceptability Pilot Study.

本文引用的文献

1
Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review.使用移动健康应用程序在参与者参与度和留存率方面面临的挑战:文献综述
J Med Internet Res. 2022 Apr 26;24(4):e35120. doi: 10.2196/35120.
2
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association.高血压的预防和治疗的体重管理策略:美国心脏协会的科学声明。
Hypertension. 2021 Nov;78(5):e38-e50. doi: 10.1161/HYP.0000000000000202. Epub 2021 Sep 20.
3
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
数字心脏健康计划中心脏自我效能的改善:一项可行性和可接受性试点研究的二次分析
JMIR Form Res. 2025 Apr 24;9:e60676. doi: 10.2196/60676.
4
How are Machine Learning and Artificial Intelligence Used in Digital Behavior Change Interventions? A Scoping Review.机器学习和人工智能如何用于数字行为改变干预?一项范围综述。
Mayo Clin Proc Digit Health. 2024 May 22;2(3):375-404. doi: 10.1016/j.mcpdig.2024.05.007. eCollection 2024 Sep.
5
The Role of Intermittent Fasting on Metabolic Syndrome: A Systematic Review and Meta-Analysis.间歇性禁食对代谢综合征的作用:一项系统评价与荟萃分析。
Cureus. 2024 Oct 16;16(10):e71623. doi: 10.7759/cureus.71623. eCollection 2024 Oct.
6
Advances in digital technology in healthcare.医疗保健领域数字技术的进展。
Hypertens Res. 2025 Feb;48(2):810-812. doi: 10.1038/s41440-024-02011-z. Epub 2024 Nov 14.
7
Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis.基于智能手机应用程序的降压干预措施:一项系统评价与荟萃分析。
Hypertens Res. 2025 Feb;48(2):492-505. doi: 10.1038/s41440-024-01939-6. Epub 2024 Oct 13.
8
Does clinical practice supported by artificial intelligence improve hypertension care management? A pilot systematic review.人工智能支持的临床实践是否能改善高血压护理管理?一项试点系统评价。
Hypertens Res. 2024 Sep;47(9):2312-2316. doi: 10.1038/s41440-024-01771-y. Epub 2024 Jul 2.
9
The Effect of an AI-Based, Autonomous, Digital Health Intervention Using Precise Lifestyle Guidance on Blood Pressure in Adults With Hypertension: Single-Arm Nonrandomized Trial.基于人工智能的自主数字健康干预结合精准生活方式指导对成人高血压患者血压的影响:单臂非随机试验
JMIR Cardio. 2024 May 28;8:e51916. doi: 10.2196/51916.
10
Evaluating a New Digital App-Based Program for Heart Health: Feasibility and Acceptability Pilot Study.评估一项基于数字应用程序的心脏健康新计划:可行性和可接受性试点研究。
JMIR Form Res. 2024 May 24;8:e50446. doi: 10.2196/50446.
降压药物治疗用于不同血压水平的心血管疾病一级和二级预防:一项个体参与者水平数据的荟萃分析。
Lancet. 2021 May 1;397(10285):1625-1636. doi: 10.1016/S0140-6736(21)00590-0.
4
The Leading Causes of Death in the US for 2020.2020年美国的主要死因。
JAMA. 2021 May 11;325(18):1829-1830. doi: 10.1001/jama.2021.5469.
5
Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.行为咨询以促进心血管疾病高危成年人的健康饮食和身体活动:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2020 Nov 24;324(20):2076-2094. doi: 10.1001/jama.2020.17108.
6
Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association.家庭自我血压监测:美国心脏协会和美国医学协会联合政策声明。
Circulation. 2020 Jul 28;142(4):e42-e63. doi: 10.1161/CIR.0000000000000803. Epub 2020 Jun 22.
7
How Behavior Change Strategies are Used to Design Digital Interventions to Improve Medication Adherence and Blood Pressure Among Patients With Hypertension: Systematic Review.行为改变策略如何用于设计数字干预措施以提高高血压患者的药物依从性和血压:系统评价
J Med Internet Res. 2020 Apr 9;22(4):e17201. doi: 10.2196/17201.
8
Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants.远程数字健康研究中的留存指标:对10万名参与者的跨研究评估
NPJ Digit Med. 2020 Feb 17;3:21. doi: 10.1038/s41746-020-0224-8. eCollection 2020.
9
Impact of therapeutic lifestyle changes in resistant hypertension.治疗性生活方式改变对耐药性高血压的影响。
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):4-9. doi: 10.1016/j.pcad.2019.11.012. Epub 2019 Nov 20.
10
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.在来自 21 个高收入、中等收入和低收入国家(PURE)的 155722 人中,可改变的风险因素、心血管疾病和死亡率:一项前瞻性队列研究。
Lancet. 2020 Mar 7;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2. Epub 2019 Sep 3.